An assessment of massive-dose chemotherapy of malignant disease.
作者信息
Bergsagel D E
出版信息
Can Med Assoc J. 1971 Jan 9;104(1):31-6.
Abstract
摘要
相似文献
1
An assessment of massive-dose chemotherapy of malignant disease.
Can Med Assoc J. 1971 Jan 9;104(1):31-6.
2
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Cancer Res. 1974 Jan;34(1):184-93.
3
4
Corticosteroid drugs: their role in oncological practice.
Med J Aust. 1986 Jan 20;144(2):81-5.
5
Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.
Cancer Chemother Rep. 1970 Dec;54(6):431-50.
6
Rationale of chemotherapeutic adjuvant treatment.
Arch Geschwulstforsch. 1978;48(7):627-35.
7
[Chemotherapy of L1210 leukemia: comparison of 7 drugs given either continuously for 20 days, or in a single massive dose, early or late].
Rev Fr Etud Clin Biol. 1968 Dec;13(10):951-60.
8
Selecting drug regimens in human leukemia.
Natl Cancer Inst Monogr. 1971 Dec;34:145-51.
9
[Study of the toxic effect of antineoplastic agents].
Farmakol Toksikol. 1971;34(1):83-91.
10
The chemotherapy of human and animal acute leukemia.
Cancer Chemother Rep. 1971 Nov;55(4):309-505.
引用本文的文献
1
Neoplastic meningitis resulting from hematological malignancies: pharmacokinetic considerations and maximizing outcome.
Clin Investig (Lond). 2011 Oct;1(10):1391-1402. doi: 10.4155/cli.11.115.
2
Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer.
Neuro Oncol. 2004 Jul;6(3):236-46. doi: 10.1215/S1152851703000668.
3
Differential effects of immunosuppressants on lymphocyte function.
J Clin Invest. 1973 Sep;52(9):2293-9. doi: 10.1172/JCI107417.
4
Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma.
Br J Cancer. 1985 Dec;52(6):867-73. doi: 10.1038/bjc.1985.271.
5
Effects of cytotoxic immunosuppressants on tuberculin-sensitive lymphocytes in guinea pigs.
J Clin Invest. 1975 Dec;56(6):1587-96. doi: 10.1172/JCI108241.
6
20-hour combination chemotherapy in advanced breast cancer.
Br Med J. 1977 Oct 22;2(6094):1064. doi: 10.1136/bmj.2.6094.1064.
7
5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus.
Br J Cancer. 1976 Aug;34(2):167-73. doi: 10.1038/bjc.1976.139.
本文引用的文献
1
The clinical excursion into 5-fluo-rouracil.
Cancer Chemother Rep. 1962 Feb;16:107-118.
2
The effect of chemotherapy on acute leukemia in the human.
J Chronic Dis. 1961 Dec;14:593-608. doi: 10.1016/0021-9681(61)90118-7.
3
A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.
Radiat Res. 1961 Feb;14:213-22.
4
Modification of treatment of schedules in the management of advanced mouse leukemia with amethopterin.
J Natl Cancer Inst. 1956 Aug;17(2):203-12.
5
Survival of Burkitt's lymphoma patients in Mulago Hospital, Uganda.
Br Med J. 1967 Nov 11;4(5575):323-7. doi: 10.1136/bmj.4.5575.323.
6
Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to vinblastine.
J Natl Cancer Inst. 1967 Mar;38(3):393-9.
7
Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.
J Natl Cancer Inst. 1966 Aug;37(2):233-45.
8
Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962.
Cancer Res. 1965 Dec;25(11):1876-81.
9
Effects of vinblastine on the proliferative capacity of L cells and their progress through the division cycle.
Cancer Res. 1965 Sep;25(8):1232-7.
10
Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to tritiated thymidine.
J Natl Cancer Inst. 1965 Jun;34(6):849-56.
Zotero 插件